VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia

Status unconfirmed · Phase 2

Conditions studied: Leukemia

In brief

RATIONALE: Drugs used in chemotherapy, such as VNP40101M and cytarabine, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving VNP40101M followed by cytarabine may kill more cancer cells. PURPOSE: This phase II trial is studying how well VNP40101M followed by cytarabine works in treating older patients with acute myeloid leukemia.

Key facts

Study ID

NCT00354276

Run by

Vion Pharmaceuticals

People needed

85

Starts

2006-05-01

Last updated by the study team

2014-01-10

Who can join

Age: 60 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Jonsson Comprehensive Cancer Center at UCLA — Los Angeles, California, United States
• Hopital Haut Leveque — Pessac, France
• University Hospital of Wales — Cardiff, Wales, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.